GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Epi Biotech Co Ltd (XKRX:446440) » Definitions » LT-Debt-to-Total-Asset

Epi Biotech Co (XKRX:446440) LT-Debt-to-Total-Asset : 0.00 (As of . 20)


View and export this data going back to 2023. Start your Free Trial

What is Epi Biotech Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Epi Biotech Co's long-term debt to total assests ratio for the quarter that ended in . 20 was 0.00.

Epi Biotech Co's long-term debt to total assets ratio stayed the same from . 20 (0.00) to . 20 (0.00).

Epi Biotech Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Epi Biotech Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epi Biotech Co LT-Debt-to-Total-Asset Chart

Epi Biotech Co Annual Data
Trend
LT-Debt-to-Total-Asset

Epi Biotech Co Semi-Annual Data
LT-Debt-to-Total-Asset

Epi Biotech Co LT-Debt-to-Total-Asset Calculation

Epi Biotech Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in . 20 is calculated as

LT Debt to Total Assets (A: . 20 )=Long-Term Debt & Capital Lease Obligation (A: . 20 )/Total Assets (A: . 20 )
=/
=

Epi Biotech Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in . 20 is calculated as

LT Debt to Total Assets (Q: . 20 )=Long-Term Debt & Capital Lease Obligation (Q: . 20 )/Total Assets (Q: . 20 )
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Epi Biotech Co  (XKRX:446440) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Epi Biotech Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Epi Biotech Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Epi Biotech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Epi Biotech Co Ltd (XKRX:446440) » Definitions » LT-Debt-to-Total-Asset
Comparable Companies
XKRX:283100 XKRX:179530 XKRX:343090 XKRX:950220 XKRX:215380 XKRX:322970 XKRX:072520 XKRX:251280 XKRX:344860 XKRX:208340 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
32, Songdogwahak-ro, Rooms 1903 and 1904, 15th floor, M-dong, Yeonsu-gu, Incheon, KOR, 21984
Website
http://www.epibiotech.com
Epi Biotech Co Ltd is developing various pipelines for each hair loss treatment modality. It also conducts R&D in skin regeneration treatments to create commercially viable consumer products. The company specializes in hair loss treatment in Korea.

Epi Biotech Co Headlines

No Headlines